Advancing ketamine in the treatment hierarchy for refractory depression
Evidence indicates that ketamine is highly effective, has a lower side effect profile and is better tolerated compared to many augmentation strategies for refractory depression. This, combined with data on psychiatric treatment outcome mediators, suggests that earlier intervention with ketamine could improve outcomes for patients suffering from refractory depression.
Authors
- Fernando Espí Forcén (ORCID: https://orcid.org/0000-0002-1119-343X)
- Kabir Nigam (ORCID: https://orcid.org/0000-0002-1880-0079)
- Franklin King (ORCID: https://orcid.org/0000-0003-4381-4242)
Institutions
- Brigham and Women's Hospital (US)
- McLean Hospital (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- The British Journal of Psychiatry
- Published
- 2024-10-25
- DOI
- https://doi.org/10.1192/bjp.2024.217
- Citations
- 2
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.90